Renaissance Technologies’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.3M | Buy |
3,307,429
+413,400
| +14% | +$1.42M | 0.02% | 994 |
|
|
2025
Q1 | $6.45M | Buy |
2,894,029
+407,136
| +16% | +$908K | 0.01% | 1266 |
|
|
2024
Q4 | $7.29M | Sell |
2,486,893
-459,810
| -16% | -$1.35M | 0.01% | 1201 |
|
|
2024
Q3 | $7.66M | Buy |
2,946,703
+1,218,100
| +70% | +$3.17M | 0.01% | 1183 |
|
|
2024
Q2 | $5.12M | Buy |
1,728,603
+239,000
| +16% | +$707K | 0.01% | 1282 |
|
|
2024
Q1 | $6.75M | Buy |
1,489,603
+30,100
| +2% | +$136K | 0.01% | 1220 |
|
|
2023
Q4 | $8.33M | Sell |
1,459,503
-232,550
| -14% | -$1.33M | 0.01% | 1039 |
|
|
2023
Q3 | $7.78M | Sell |
1,692,053
-844,550
| -33% | -$3.88M | 0.01% | 1067 |
|
|
2023
Q2 | $16.4M | Sell |
2,536,603
-274,900
| -10% | -$1.78M | 0.02% | 769 |
|
|
2023
Q1 | $21.2M | Buy |
2,811,503
+689,100
| +32% | +$5.2M | 0.03% | 679 |
|
|
2022
Q4 | $21.5M | Sell |
2,122,403
-858,400
| -29% | -$8.7M | 0.03% | 676 |
|
|
2022
Q3 | $29.5M | Sell |
2,980,803
-1,055,500
| -26% | -$10.4M | 0.04% | 497 |
|
|
2022
Q2 | $43M | Buy |
4,036,303
+1,418,700
| +54% | +$15.1M | 0.05% | 404 |
|
|
2022
Q1 | $25.5M | Buy |
2,617,603
+2,078,400
| +385% | +$20.3M | 0.03% | 631 |
|
|
2021
Q4 | $7.71M | Buy |
539,203
+454,903
| +540% | +$6.51M | 0.01% | 1217 |
|
|
2021
Q3 | $1.69M | Sell |
84,300
-318,900
| -79% | -$6.39M | ﹤0.01% | 2219 |
|
|
2021
Q2 | $8.87M | Buy |
+403,200
| New | +$8.87M | 0.01% | 1261 |
|